Connection

DAVID NELSON to Female

This is a "connection" page, showing publications DAVID NELSON has written about Female.
Connection Strength

0.421
  1. Ectopic expression of CGG-repeats alters ovarian response to gonadotropins and leads to infertility in a murine FMR1 premutation model. Hum Mol Genet. 2021 05 29; 30(10):923-938.
    View in: PubMed
    Score: 0.029
  2. Assessing the Safety of Direct-Acting Antiviral Agents for Hepatitis C. JAMA Netw Open. 2019 06 05; 2(6):e194765.
    View in: PubMed
    Score: 0.025
  3. Pragmatic trial of a Study Navigator Model (NAU) vs. Ambassador Model (N+) to increase enrollment to health research among community members who use illicit drugs. Drug Alcohol Depend. 2017 06 01; 175:146-150.
    View in: PubMed
    Score: 0.022
  4. All-oral 12-week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY-3 phase III study. Hepatology. 2015 Apr; 61(4):1127-35.
    View in: PubMed
    Score: 0.019
  5. The Fragile X proteins Fmrp and Fxr2p cooperate to regulate glucose metabolism in mice. Hum Mol Genet. 2015 Apr 15; 24(8):2175-84.
    View in: PubMed
    Score: 0.019
  6. Subsequent pregnancy outcomes in women previously diagnosed with subclinical hypothyroidism. Am J Perinatol. 2014 Jan; 31(1):77-84.
    View in: PubMed
    Score: 0.016
  7. Altered hippocampal synaptic plasticity in the FMR1 gene family knockout mouse models. J Neurophysiol. 2009 May; 101(5):2572-80.
    View in: PubMed
    Score: 0.012
  8. Argonaute-2-dependent rescue of a Drosophila model of FXTAS by FRAXE premutation repeat. Hum Mol Genet. 2007 Oct 01; 16(19):2326-32.
    View in: PubMed
    Score: 0.011
  9. Chromosomal microarray analysis (CMA) detects a large X chromosome deletion including FMR1, FMR2, and IDS in a female patient with mental retardation. Am J Med Genet A. 2007 Jun 15; 143A(12):1358-65.
    View in: PubMed
    Score: 0.011
  10. International integrated database for the evaluation of severe sepsis and drotrecogin alfa (activated) therapy: 28-day survival and safety. J Crit Care. 2007 Jun; 22(2):142-52.
    View in: PubMed
    Score: 0.011
  11. Improving Maternal Postpartum Access to Care through Telemedicine (IMPACT): A multi-center randomized controlled trial of postpartum interventions to improve access and outcome. Contemp Clin Trials. 2025 May; 152:107882.
    View in: PubMed
    Score: 0.009
  12. Care Models to Improve Pain and Reduce Opioids Among Patients Prescribed Long-Term Opioid Therapy: The VOICE Randomized Clinical Trial. JAMA Intern Med. 2025 Feb 01; 185(2):208-220.
    View in: PubMed
    Score: 0.009
  13. Genetics. The critical region in trisomy 21. Science. 2004 Oct 22; 306(5696):619-21.
    View in: PubMed
    Score: 0.009
  14. Instability of a premutation-sized CGG repeat in FMR1 YAC transgenic mice. Genomics. 2002 Oct; 80(4):423-32.
    View in: PubMed
    Score: 0.008
  15. A recurrent deletion in the ubiquitously expressed NEMO (IKK-gamma) gene accounts for the vast majority of incontinentia pigmenti mutations. Hum Mol Genet. 2001 Sep 15; 10(19):2171-9.
    View in: PubMed
    Score: 0.007
  16. A Pragmatic, Randomized Controlled Trial of Oral Antivirals for the Treatment of Chronic Hepatitis C: The PRIORITIZE Study. Hepatology. 2021 12; 74(6):2952-2964.
    View in: PubMed
    Score: 0.007
  17. Prevalence and cardiometabolic correlates of ketohexokinase gene variants among UK Biobank participants. PLoS One. 2021; 16(2):e0247683.
    View in: PubMed
    Score: 0.007
  18. Deletion of Fmr1 from Forebrain Excitatory Neurons Triggers Abnormal Cellular, EEG, and Behavioral Phenotypes in the Auditory Cortex of a Mouse Model of Fragile X Syndrome. Cereb Cortex. 2020 03 14; 30(3):969-988.
    View in: PubMed
    Score: 0.007
  19. Natural History of Ground-Glass Lesions Among Patients With Previous Lung Cancer. Ann Thorac Surg. 2018 06; 105(6):1671-1677.
    View in: PubMed
    Score: 0.006
  20. Multisite Investigation of Outcomes With?Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention. JACC Cardiovasc Interv. 2018 01 22; 11(2):181-191.
    View in: PubMed
    Score: 0.006
  21. Glecaprevir and Pibrentasvir in Patients with HCV and Severe Renal Impairment. N Engl J Med. 2017 10 12; 377(15):1448-1455.
    View in: PubMed
    Score: 0.006
  22. Infant outcomes among women with Zika virus infection?during pregnancy: results of a large prenatal?Zika?screening program. Am J Obstet Gynecol. 2017 Mar; 216(3):292.e1-292.e8.
    View in: PubMed
    Score: 0.005
  23. Selection against mutant alleles in blood leukocytes is a consistent feature in Incontinentia Pigmenti type 2. Hum Mol Genet. 1996 Nov; 5(11):1777-83.
    View in: PubMed
    Score: 0.005
  24. Genetic variation and evolutionary stability of the FMR1 CGG repeat in six closed human populations. Am J Med Genet. 1996 Jul 12; 64(1):220-5.
    View in: PubMed
    Score: 0.005
  25. Identification of FMR2, a novel gene associated with the FRAXE CCG repeat and CpG island. Nat Genet. 1996 May; 13(1):109-13.
    View in: PubMed
    Score: 0.005
  26. Interferon-free therapy for genotype 1 hepatitis C in liver transplant recipients: Real-world experience from the hepatitis C therapeutic registry and research network. Liver Transpl. 2016 Jan; 22(1):24-33.
    View in: PubMed
    Score: 0.005
  27. An analysis of population-based prenatal screening for overt hypothyroidism. Am J Obstet Gynecol. 2015 Oct; 213(4):565.e1-6.
    View in: PubMed
    Score: 0.005
  28. De novo mutation in three families with multigenerational incontinentia pigmenti. Am J Hum Genet. 1994 Dec; 55(6):1279-81.
    View in: PubMed
    Score: 0.005
  29. Isolation of a GCC repeat showing expansion in FRAXF, a fragile site distal to FRAXA and FRAXE. Nat Genet. 1994 Nov; 8(3):229-35.
    View in: PubMed
    Score: 0.005
  30. MBD5 haploinsufficiency is associated with sleep disturbance and disrupts circadian pathways common to Smith-Magenis and fragile X syndromes. Eur J Hum Genet. 2015 Jun; 23(6):781-9.
    View in: PubMed
    Score: 0.005
  31. A de novo deletion in FMR1 in a patient with developmental delay. Hum Mol Genet. 1994 Sep; 3(9):1705-6.
    View in: PubMed
    Score: 0.005
  32. Treatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin. N Engl J Med. 2014 Apr 24; 370(17):1594-603.
    View in: PubMed
    Score: 0.004
  33. Frequency and stability of the fragile X premutation. Hum Mol Genet. 1994 Mar; 3(3):393-8.
    View in: PubMed
    Score: 0.004
  34. Advances in molecular analysis of fragile X syndrome. JAMA. 1994 Feb 16; 271(7):536-42.
    View in: PubMed
    Score: 0.004
  35. Genome of the house fly, Musca domestica L., a global vector of diseases with adaptations to a septic environment. Genome Biol. 2014; 15(10):466.
    View in: PubMed
    Score: 0.004
  36. Regional assignment of 19 X-linked ESTs. Hum Mol Genet. 1993 Nov; 2(11):1901-5.
    View in: PubMed
    Score: 0.004
  37. Relationship between muscle mass and muscle strength, and the impact of comorbidities: a population-based, cross-sectional study of older adults in the United States. BMC Geriatr. 2013 Jul 16; 13:74.
    View in: PubMed
    Score: 0.004
  38. Trinucleotide repeat instability: when and where? Nat Genet. 1993 Jun; 4(2):107-8.
    View in: PubMed
    Score: 0.004
  39. CC genotype donors for the interleukin-28B single nucleotide polymorphism are associated with better outcomes in hepatitis C after liver transplant. Liver Int. 2013 Jan; 33(1):72-8.
    View in: PubMed
    Score: 0.004
  40. Sonographic findings in two cases of complicated pregnancy in women previously treated with endometrial ablation. J Clin Ultrasound. 2013 Nov-Dec; 41(9):566-9.
    View in: PubMed
    Score: 0.004
  41. Triplet repeat mutations in human disease. Science. 1992 May 08; 256(5058):784-9.
    View in: PubMed
    Score: 0.004
  42. AGG interruptions within the maternal FMR1 gene reduce the risk of offspring with fragile X syndrome. Genet Med. 2012 Aug; 14(8):729-36.
    View in: PubMed
    Score: 0.004
  43. Chemical screen reveals small molecules suppressing fragile X premutation rCGG repeat-mediated neurodegeneration in Drosophila. Hum Mol Genet. 2012 May 01; 21(9):2068-75.
    View in: PubMed
    Score: 0.004
  44. FXR1P but not FMRP regulates the levels of mammalian brain-specific microRNA-9 and microRNA-124. J Neurosci. 2011 Sep 28; 31(39):13705-9.
    View in: PubMed
    Score: 0.004
  45. Retrotransposon activation contributes to fragile X premutation rCGG-mediated neurodegeneration. Hum Mol Genet. 2012 Jan 01; 21(1):57-65.
    View in: PubMed
    Score: 0.004
  46. Ablation of Fmrp in adult neural stem cells disrupts hippocampus-dependent learning. Nat Med. 2011 May; 17(5):559-65.
    View in: PubMed
    Score: 0.004
  47. Process of care and outcomes in patients with peripheral arterial disease. J Gen Intern Med. 2007 Jul; 22(7):942-8.
    View in: PubMed
    Score: 0.003
  48. Virological response and safety outcomes in therapy-nai ve patients treated for chronic hepatitis C with taribavirin or ribavirin in combination with pegylated interferon alfa-2a: a randomized, phase 2 study. J Hepatol. 2007 Jul; 47(1):51-9.
    View in: PubMed
    Score: 0.003
  49. Secretin receptor-deficient mice exhibit impaired synaptic plasticity and social behavior. Hum Mol Genet. 2006 Nov 01; 15(21):3241-50.
    View in: PubMed
    Score: 0.003
  50. Exaggerated behavioral phenotypes in Fmr1/Fxr2 double knockout mice reveal a functional genetic interaction between Fragile X-related proteins. Hum Mol Genet. 2006 Jun 15; 15(12):1984-94.
    View in: PubMed
    Score: 0.003
  51. Benefits of telephone care over primary care for smoking cessation: a randomized trial. Arch Intern Med. 2006 Mar 13; 166(5):536-42.
    View in: PubMed
    Score: 0.003
  52. The DNA sequence of the human X chromosome. Nature. 2005 Mar 17; 434(7031):325-37.
    View in: PubMed
    Score: 0.002
  53. Somatic and germline instability of the ATTCT repeat in spinocerebellar ataxia type 10. Am J Hum Genet. 2004 Jun; 74(6):1216-24.
    View in: PubMed
    Score: 0.002
  54. Cytogenetic analysis of obsessive-compulsive disorder (OCD): identification of a FRAXE fragile site. Am J Med Genet A. 2003 Apr 01; 118A(1):25-8.
    View in: PubMed
    Score: 0.002
  55. Multiple pathogenic and benign genomic rearrangements occur at a 35 kb duplication involving the NEMO and LAGE2 genes. Hum Mol Genet. 2001 Oct 15; 10(22):2557-67.
    View in: PubMed
    Score: 0.002
  56. Atypical forms of incontinentia pigmenti in male individuals result from mutations of a cytosine tract in exon 10 of NEMO (IKK-gamma). Am J Hum Genet. 2001 Mar; 68(3):765-71.
    View in: PubMed
    Score: 0.002
  57. Large expansion of the ATTCT pentanucleotide repeat in spinocerebellar ataxia type 10. Nat Genet. 2000 Oct; 26(2):191-4.
    View in: PubMed
    Score: 0.002
  58. Filamin (FLN1), plexin (SEX), major palmitoylated protein p55 (MPP1), and von-Hippel Lindau binding protein (VBP1) are not involved in incontinentia pigmenti type 2. Am J Med Genet. 2000 Sep 04; 94(1):79-84.
    View in: PubMed
    Score: 0.002
  59. Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium. Nature. 2000 May 25; 405(6785):466-72.
    View in: PubMed
    Score: 0.002
  60. Human homologue of the murine bare patches/striated gene is not mutated in incontinentia pigmenti type 2. Am J Med Genet. 2000 Mar 20; 91(3):241-4.
    View in: PubMed
    Score: 0.002
  61. Mutation analysis of the DKC1 gene in incontinentia pigmenti. J Med Genet. 1999 Nov; 36(11):860-2.
    View in: PubMed
    Score: 0.002
  62. X-linked situs abnormalities result from mutations in ZIC3. Nat Genet. 1997 Nov; 17(3):305-8.
    View in: PubMed
    Score: 0.001
  63. Predisposition to the fragile X syndrome in Jews of Tunisian descent is due to the absence of AGG interruptions on a rare Mediterranean haplotype. Am J Hum Genet. 1997 Jan; 60(1):103-12.
    View in: PubMed
    Score: 0.001
  64. Large domains of apparent delayed replication timing associated with triplet repeat expansion at FRAXA and FRAXE. Am J Hum Genet. 1996 Aug; 59(2):407-16.
    View in: PubMed
    Score: 0.001
  65. Gonadal mosaicism for incontinentia pigmenti in a healthy male. J Med Genet. 1995 Nov; 32(11):887-90.
    View in: PubMed
    Score: 0.001
  66. The fragile X premutation in carriers and its effect on mutation size in offspring. Am J Hum Genet. 1995 May; 56(5):1147-55.
    View in: PubMed
    Score: 0.001
  67. Loss of mutation at the FMR1 locus through multiple exchanges between maternal X chromosomes. Hum Mol Genet. 1994 Oct; 3(10):1823-7.
    View in: PubMed
    Score: 0.001
  68. Reliability of diagnostic assessment of normal and premutation status in the fragile X syndrome using DNA testing. Am J Med Genet. 1994 Jul 15; 51(4):339-45.
    View in: PubMed
    Score: 0.001
  69. High resolution methylation analysis of the FMR1 gene trinucleotide repeat region in fragile X syndrome. Hum Mol Genet. 1993 Oct; 2(10):1659-65.
    View in: PubMed
    Score: 0.001
  70. Human and murine FMR-1: alternative splicing and translational initiation downstream of the CGG-repeat. Nat Genet. 1993 Jul; 4(3):244-51.
    View in: PubMed
    Score: 0.001
  71. Characterization of three overlapping deletions causing X-linked lymphoproliferative disease. Genomics. 1993 Apr; 16(1):254-5.
    View in: PubMed
    Score: 0.001
  72. Direct versus indirect molecular diagnosis of fragile X mental retardation in 40 German families at risk. J Med Genet. 1993 Mar; 30(3):193-7.
    View in: PubMed
    Score: 0.001
  73. Frequent small amplifications in the FMR-1 gene in fra(X) families: limits to the diagnosis of 'premutations'. J Med Genet. 1992 Nov; 29(11):802-6.
    View in: PubMed
    Score: 0.001
  74. Genome analysis and the human X chromosome. Science. 1992 Oct 02; 258(5079):103-9.
    View in: PubMed
    Score: 0.001
  75. DNA methylation represses FMR-1 transcription in fragile X syndrome. Hum Mol Genet. 1992 Sep; 1(6):397-400.
    View in: PubMed
    Score: 0.001
  76. The Lowe's oculocerebrorenal syndrome gene encodes a protein highly homologous to inositol polyphosphate-5-phosphatase. Nature. 1992 Jul 16; 358(6383):239-42.
    View in: PubMed
    Score: 0.001
  77. Intragenic probe used for diagnostics in fragile X families. Am J Med Genet. 1992 Apr 15-May 1; 43(1-2):192-6.
    View in: PubMed
    Score: 0.001
  78. Characterization of a highly polymorphic dinucleotide repeat 150 KB proximal to the fragile X site. Am J Med Genet. 1992 Apr 15-May 1; 43(1-2):237-43.
    View in: PubMed
    Score: 0.001
  79. Isolation of cDNA sequences around the chromosomal breakpoint in a female with Lowe syndrome by direct screening of cDNA libraries with yeast artificial chromosomes. J Inherit Metab Dis. 1992; 15(4):526-31.
    View in: PubMed
    Score: 0.001
  80. Expression and regulation of human low-density lipoprotein receptors in Chinese hamster ovary cells. Nature. 1984 Feb 23-29; 307(5953):742-5.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.